洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2000039981】The Increase in the Ratio of Transverse Colon Diameter to Lumbar Vertebral Corpus Diameter in Acute Left Colon Tumor Obstruction is Indicator of Morbidity

基本信息
登记号

ChiCTR2000039981

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-11-16

临床申请受理号

/

靶点

/

适应症

acute obstructive left-sided colorectal cancer

试验通俗题目

The Increase in the Ratio of Transverse Colon Diameter to Lumbar Vertebral Corpus Diameter in Acute Left Colon Tumor Obstruction is Indicator of Morbidity

试验专业题目

The Increase in the Ratio of Transverse Colon Diameter to Lumbar Vertebral Corpus Diameter in Acute Left Colon Tumor Obstruction is Indicator of Morbidity

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

to evaluate the relationship between postoperative complications and preoperative colon diameter increase rate in patients that have undergone Hartman procedure.

试验分类
请登录查看
试验类型

连续入组

试验分期

回顾性研究

随机化

It was obtained from the patient database of the University of Health Sciences Tepecik Training and Research Hospital.

盲法

N/A

试验项目经费来源

None

试验范围

/

目标入组人数

49

实际入组人数

/

第一例入组时间

2017-01-01

试验终止时间

2018-02-01

是否属于一致性

/

入选标准

Underwent emergency Hartman procedure due to acute obstructive left-sided colorectal cancer, aged >= 18 years (retrospective).;

排除标准

Intraoperative perforation, patients whose abdominal computed tomography weren't done within the last 48 hours preoperatively, and patients that had intraoperative peritonitis carcinomatosis (retrospective).;

研究者信息
研究负责人姓名
请登录查看
试验机构

ALİ KEMAL KAYAPINAR

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

University of Health Sciences Tepecik Training and Research Hospital, Department of General Surgery,的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用